methyl 2,2-dimethyl-3,3-diphenylpropanoate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 2,2-dimethyl-3,3-diphenylpropanoate
• 英文别名: 2,2-dimethyl-3,3-diphenyl-propionic acid methyl ester；2,2-Dimethyl-3,3-diphenyl-propionsaeure-methylester
• 化学式: C₁₈H₂₀O₂
• 分子量: 268.356
• InChiKey: BXRDBYKWRRKBBN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  methyl 2,2-dimethyl-3,3-diphenylpropanoate 生成 2,2-Dimethyl-3,3-diphenyl-propionsaeure
  参考文献：
  名称：

  Ketene Acetals. XXX. Alkylation of Dimethylketene Dimethylacetal

  摘要：

  DOI：

  10.1021/ja01112a033
• 作为产物：
  描述：

  1-甲氧基-1-(三甲基甲硅氧基)-2-甲基-1-丙烯 、 乙酸二苯甲酯 在 iron(III) trifluoromethanesulfonate 作用下， 以 1,2-二氯乙烷 为溶剂， 反应 6.0h， 以92%的产率得到methyl 2,2-dimethyl-3,3-diphenylpropanoate
  参考文献：
  名称：

  Fe(OTf)3-催化乙酸苄酯与有机硅化合物的反应

  摘要：

  Fe(OTf) 3 催化苄基乙酸酯与烯丙基三甲基硅烷、叠氮基三甲基硅烷和氰基三甲基硅烷反应以高产率得到相应的烯丙基化、叠氮基和氰基产物。2-三甲基甲硅烷基取代的苯并呋喃和吲哚可以很好地制备苄基取代的苯并呋喃和吲哚。

  DOI：

  10.1055/s-0030-1259313

文献信息

• Rhenium complex-catalyzed carbon-carbon formation of alcohols and organosilicon compounds
  作者：Rui Umeda、Toshifumi Jikyo、Kazuki Toda、Issey Osaka、Yutaka Nishiyama

  DOI：10.1016/j.tetlet.2018.02.019

  日期：2018.3

  The coupling reactions of allylic and benzylic alcohols and allyltrimethylsilane are efficiently catalyzed by a rhenium complex to give the corresponding 1,5-dienes and alkenes in moderate to good yields. Similarly, alcohols were coupled with ketene silyl acetals to form the corresponding esters.

  a络合物可有效催化烯丙基和苄醇与烯丙基三甲基硅烷的偶联反应，以中等至良好的收率得到相应的1,5-二烯和烯烃。类似地，将醇与乙烯酮甲硅烷基缩醛偶联以形成相应的酯。
• One-Pot Hydroxy Group Activation/Carbon-Carbon Bond Forming Sequence Using a Brønsted Base/Brønsted Acid System
  作者：Alice Devineau、Guillaume Pousse、Catherine Taillier、Jérôme Blanchet、Jacques Rouden、Vincent Dalla

  DOI：10.1002/adsc.201000602

  日期：2010.11.22

  distinct feature of the trichloroacetimidate group allows use of weaker acid catalysts such as 1,1′-bi-2-naphthol (BINOL)-derived phosphoric acid, pointing out the possible development of an enantioselective variant. This unprecedented sequential one-pot Brønsted base-Brønsted acid catalysis further expands the synthetic scope of the trichloroacetimidate group.

  提出了一种新的连续两步多催化策略，该策略包括有效的DBU催化的醇的三氯乙酰亚胺化，然后由硅基亲核试剂和CH亲核试剂进行双三氟乙胺（Tf 2 NH）催化的分子间烷基化。三氯乙酰基亚氨酸酯基团的独特特征允许使用弱酸催化剂，例如1,1'-联-2-萘酚（BINOL）衍生的磷酸，指出了对映选择性变体的可能发展。这种前所未有的连续一锅法布朗斯台德碱布朗斯台德酸催化进一步扩大了三氯乙酰亚胺基的合成范围。
• Amido compounds as RORγt modulators and uses thereof
  申请人：New York University

  公开号：US10561666B2

  公开（公告）日：2020-02-18

  Amido compounds are disclosed that have a formula represented by the following: and wherein n1, n2, R1a, R1b, R2, R3, R4, R5, and R6 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.

  本发明公开了具有下式表示的氨基化合物： 其中 n1、n2、R1a、R1b、R2、R3、R4、R5 和 R6 如本文所述。这些化合物可制备成药物组合物，并可用于预防和治疗包括人类在内的哺乳动物的各种疾病，包括非限制性的炎症、自身免疫性疾病、癌症和移植物抗宿主疾病。
• AMIDO COMPOUNDS AS RORyT MODULATORS AND USES THEREOF
  申请人：Littman Dan

  公开号：US20130085162A1

  公开（公告）日：2013-04-04

  Amido compounds are disclosed that have a formula represented by the following: and wherein n1, n2, R 1a , R 1b , R 2 , R 3 , R 4 , R 5 , and R 6 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.
• AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF
  申请人：LITTMAN Dan

  公开号：US20170065606A1

  公开（公告）日：2017-03-09

  Amido compounds are disclosed that have a formula represented by the following: and wherein n1, n2, R 1a , R 1b , R 2 , R 3 , R 4 , R 5 , and R 6 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.